Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지

The relation between angiotensin converting enzyme (ACE) gene polymorphism and neonatal hyperbilirubinemia in Korea

한국인 신생아 황달과 안지오텐신 전환효소 유전자의 다형성

  • Kim, Mi Yeoun (Department of Pediatrics, Sung-Ae General Hospital) ;
  • Lee, Jae Myoung (Department of Pediatrics, Sung-Ae General Hospital) ;
  • Kim, Ji Sook (Department of Pediatrics, Sung-Ae General Hospital) ;
  • Kim, Eun Ryoung (Department of Pediatrics, Sung-Ae General Hospital) ;
  • Lee, Hee Jae (Department of Pharmacology, College of Medicine, Kangwon National University) ;
  • Yoon, Seo Hyun (Department of Pharmacology, College of Medicine, Kyunghee University) ;
  • Chung, Joo Ho (Department of Pharmacology, College of Medicine, Kyunghee University)
  • 김미연 (성애병원 소아과) ;
  • 이재명 (성애병원 소아과) ;
  • 김지숙 (성애병원 소아과) ;
  • 김은령 (성애병원 소아과) ;
  • 이희제 (강원대학교 의과대학 약리학교실) ;
  • 윤서현 (경희대학교 의과대학 약리학교실) ;
  • 정주호 (경희대학교 의과대학 약리학교실)
  • Received : 2006.08.29
  • Accepted : 2006.09.27
  • Published : 2007.01.15
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose : Human angiotensin converting enzyme (ACE) gene shows an insertion/deletion polymorphism in 16 intron, and three genotypes are determined by whether a 287 bp fragment of the DNA is present or not; II, ID and DD genotype. DD genotype has been suggested as a risk factor of chronic nephrotic disease such as IgA nephropathy and diabetic nephropathy, various cardiovascular diseases and several other diseases. ACE activity increases in acute hepatitis, chronic persistent hepatitis, chronic active hepatitis and cirrhosis. On the other hand, patients with fatty livers have normal ACE activity. This study was designed to find out the relation between polymorphsims of the ACE genes and neonatal hyperbilirubinemia in Koreans. Methods : The genomic DNA was isolated from 110 full-term Korean neonates who had hyperbilirubinemia with no obvious causes (serum bilirubin$${\geq_-}12mg/dL$$) and 164 neonates of a control population (serum bilirubin <12 mg/dL). We performed polymerase chain reaction (PCR) to see the allele of the ACE gene. Electrophoresis was done in the PCR products in 1.5 percent agarose gel, and then DNA patterns were directly visualized under ethidium bromide staining. Results : ACE genotypes in the hyperbilirubinemia group are as follows; 26.36 percent for II, 53.64 percent for ID, 20.00 percent for DD, 0.532 for I allele and 0.468 for D allele. These distributions were not significantly different from those in the control group; 24.39 percent for II, 51.83 percent for DI, 23.78 percent for DD, 0.503 for I allele and 0.497 for D allele. Conclusion : In this study, ACE gene polymorphism was detected in the neonatal hyperbilirubinemia and control group. The most frequent genotype was ID. Our results indicate that the ACE gene polymorphism is not associated with the prevalence of neonatal hyperbilirubinemia in Koreans.

목 적 : ACE 유전자에 인트론 16의 287 bp 삽입(I) 혹은 결손(D)에 의한 다형성이 존재하고, 그 중 DD 유전형은 ACE 활성도가 높은 것으로 보고 되었으며 ID 다형성은 고혈압 또는 관상동맥 질환, 당뇨병성 신증, IgA 신장염 등 만성 신질환, 만성 B형 간염, 간경변증, 급성간염에서 위험인자로 알려졌다. 신생아 황달은 동아시아인이 서양인보다 2배 이상 높은 것으로 보여 유전적 연관성이 있을 것으로 사료되어 본 연구에서는 ACE 다형성과 한국인 신생아 황달과의 관계를 알아보고자 하였다. 방 법 : 혈중 빌리루빈 수치가 12 mg/dL 이상의 건강하고, 위험인자가 없는 만삭아 중 신생아 황달 환자 110명과 대조군 164명을 대상으로 하였다. 혈액을 0.5 cc를 채취하여 DNA를 분리하였고 ACE 유전자 다형성은 중합효소 연쇄반응을 이용하여 결정하였다. 1.5% agarose gel에서 전기 영동시켜 ethidium bromide로 염색한 후 유전자형을 확인하였다. 결 과 : ACE 유전자 다형성은 신생아 고빌리루빈혈증군 110명중 59명(53.6%)에서 DI 유전형을 보였고, 29명(26.4%)에서 II 유전형, 22명(20%)에서, DD 유전형을 나타냈다. 대조군 164명에서는 85명(51.8%)이 DI 유전형을 보였고, 40명(24.4%)에서 II 유전형을 보였으며, DD 유전형은 39명(23.4%)에서 나타났다. 대립유전자 빈도는 신생아 고빌리루빈혈증군에서 I 0.532, D 0.468의 분포를 보였고, 정상 대조군에서는 I 0.503, D 0.497로 비슷하였다. 결 론 : 한국 신생아에서 ACE 유전자 다형성은 DI 유전형이 많았으나, 대립유전자의 빈도는 차이가 없어 한국인 신생아 황달의 발생과 연관이 없었다.

Keywords

References

  1. Horiguchi T, Bauer C. Ethnic differences in neonatal jaundice : Comparison of japanese and Caucacian newborn infants. Am J Obstet Gynecol 1975;121:71-4 https://doi.org/10.1016/0002-9378(75)90978-3
  2. Linn S, Schoenbaum SC, Monson RR, Rosner B, Stubblefield PG, Ryan KJ. Epidemiology of neonatal hyperbilirubinemia. Pediatrics 1985;75:770-4
  3. Khoury MJ, Calle EE, Joesoef RM. Recurrence risk of neonatal hyperbilirubinemia in siblings. Am J Dis Child 1988;142:1065-9
  4. Gale R, Seidman DS, Dollberg S, Stervenson DK. Epidemiology of neonatal jaundice in the Jerusalem population. J Pediatr Gastroenterol Nutr 1990;10:82-6 https://doi.org/10.1097/00005176-199001000-00016
  5. Nielsen HE, Haase P, Blaabjerg J, Stryhn, Hilden J. Risk factors and sib correlation in physiological neonatal jaundice. Acta Paediatr Scand 1987;76:504-11 https://doi.org/10.1111/j.1651-2227.1987.tb10507.x
  6. Hong KW, Kang H, Kim IS, Kim JS, Kim ER, Lee HJ, et al. Polyrnorphsim of UDP-glucuronosyltransferase Gene (UGT1A1) of neonatal hyperbilirubinemia in Korea. Korean J Pediatr 2004;47:18-23
  7. Maruo Y, Nishizawa K, Sato H, Doida Y, Shimada M. Association of neonatal hyperbilirubinemia with bilirubin UDP-glucuronosyltransferase polymorphism. Pediatrics 1999;103:1224-7 https://doi.org/10.1542/peds.103.6.1224
  8. Huang CS, Chang PF, Huang MJ, Chen ES, Hung KL, Tsou KI. Relationship between bilirubin UDP-glucuronosyltransferase 1A1 gene and neonatal hyperbilirubinemia. Pediatr Res 2002;52:601-5 https://doi.org/10.1203/00006450-200210000-00022
  9. Kang H, Lim JH, Kim JS, Kim ER, Kim SD, Lee HJ, et al. The association of neonatal hyperbilirubinemia with UGT1A1 and CYP1A2 gene polymorphism in Korean neonate. Korean J Pediatr 2005;48:35-41
  10. Huang CS, Luo GA, Huang MJ, Yu SC, Yang SS. Variation of the bilirubin uridine-diphosphoglucuronosyl trasnferase lAl gene in healthy Taiwanese. Pharmacogenetics 2000;10:539-44 https://doi.org/10.1097/00008571-200008000-00007
  11. Koiwai O, Nishizawa M, Hasada K, Aono S, Adachi Y, Mamiya N, et al. Gilbert's syndrome is caused by a heterozygous missense mutation in the gene for bilirubin UDP-glucuronosytransferase. Hum Mol Genet 1995;4:1183-6 https://doi.org/10.1093/hmg/4.7.1183
  12. Yamamoto K, Sato H, Fujiyama Y, Doida Y, Bamba T. Contribution of two missense mutaions(G71R and Y486D) of the bilirubin UDP glucuronosytransferase(UGT1A1) gene to phenotypes of Gilbert's syndrome and Crigler-Najjar syndrome type II. Biochim Biophys Acta 1998;1406:267-73 https://doi.org/10.1016/S0925-4439(98)00013-1
  13. Maruo Y, Addario CD, Mori A, Iwai M, Takahashi H, Sato H, et al. Two linked polymorphic mutaions(A(TA)7TAA and T-3279G) of UGT1A1 as the principal cause of Gilbert syndrome. Hum Genet 2004;115:525-6 https://doi.org/10.1007/s00439-004-1183-x
  14. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Carvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin Iconverting enzyme gene accounting for half the variance of serum enzyme level. J Clin Invest 1990;86:1343-6 https://doi.org/10.1172/JCI114844
  15. Hubert C, Houot AM, Corvol P, Soubrier F. Structure of the angiotensin I-converting enzyme gene. J Biol Chem 1991;266:15377-83
  16. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, et al. Evidence from combined segregation and linkage analysis that a variant of the angiotensin I-converting enzyme(ACE) gene controls plasma ACE levels. AM J Hum Genet 1992;51:197-205
  17. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992;359:641-4 https://doi.org/10.1038/359641a0
  18. Doria A, Warram JH, Krolewski AS. Genetic predisposition to diabetic nephropathy evidence for a role of the angiotensin I-converting enzyme gene. Diabetes 1994;43:690-5 https://doi.org/10.2337/diabetes.43.5.690
  19. Amouyel P, Richard F, Berr C, Fromentin ID, Helbecque N. The renin angiotensin system and Alzheimer's disease. Ann N Y Acad Sci 2000;903;437-41 https://doi.org/10.1111/j.1749-6632.2000.tb06395.x
  20. Cho SW, Kim HS, Song JM, Choi JH, Lee SC, Kim CH, et al. Correlation between insertion/deletion polymorphism of angiotensin I-converting enzyme gene and left ventricular hypertrophy. Korean Circulation Journal 1996;26:14-9 https://doi.org/10.4070/kcj.1996.26.1.14
  21. Toniutto P, Fabris C, Minisini R, Apollonio L, Fumo E, Caldato M, et al. Weight gain after liver transplantation and the Insertion/Deletion polymorphsim of the angiotensin-converting enzyme gene. Transplantation 2005;79:1338-43 https://doi.org/10.1097/01.TP.0000158712.42875.51
  22. Choi YH, Rhee JC. Angiotensin-converting enzyme gene polymorphism is associated with chronic HBV infection. Korean J Gastroenterol 1997;29;489-96
  23. Matsuki K, Sakata T. Angiotensin-converting enzyme in disease of the liver. Am J Med 1982;73:549-51 https://doi.org/10.1016/0002-9343(82)90335-7
  24. Johnson DA, Diehl AM, Sjogren MH, Lazar J, Cattau E, Smallridge RC. Serum angiotensin converting enzyme activity in evaluation of patients with liver disease. Am J Med 1987;83:256-60 https://doi.org/10.1016/0002-9343(87)90694-2
  25. Dzau VJ, Re R. Tissue angiotensin system in cardiovascular medicine: A paradigm shift? Ciculation 1994;89:493-8 https://doi.org/10.1161/01.CIR.89.1.493
  26. Haas E, Goldblatt H. Kinetic constants of the human renin and human angiotensinogen reaction. Circ Res 1967;20:45-55 https://doi.org/10.1161/01.RES.20.1.45
  27. Schachter F, Faure-Delanef L, Guenot F, Rouger H, Froguel P, Lesueur-Ginot L, et al. Genetic association with human longevity at the APOE and ACE loci. Nature Genetics 1994;6:4-5 https://doi.org/10.1038/ng0194-4
  28. Costerousse O, Allegrini J, Lopez M, Gelas FA. Angiotensin I converting enzyme in human circulation mononuclear cells: genetic polymorphism of expression in T lymphocytes. Biochem J 1993;290:33-40 https://doi.org/10.1042/bj2900033
  29. Ehlers MRW, Riordan JF. Angiotensin-converting enzyme: new concepts concerning its biological role. Biochemistry 1989;28:5311-3 https://doi.org/10.1021/bi00439a001
  30. Ouellette DR, Kelly JW, Anders GT. Serum angiotensin-converting enzyme level in patients with human immunodeficiency virus infection. Arch Intern Med 1992;152:321-4 https://doi.org/10.1001/archinte.152.2.321
  31. Barley J, Blackwood A, Carter ND, Crews DE, Cruickshank JK, Jeffery S, et al. Angiotensin converting enzyme insertion/deletion polymorphism: association with ethnic orgin. J of hypertension 1994;12:955-7
  32. Lee EJ. Population genetics of the angiotensin-converting enzyme in Chinese. Br J Clin Pharmac 1994;37:212-4 https://doi.org/10.1111/j.1365-2125.1994.tb04264.x
  33. Harden PN, Geddes C, Rowe PA, Mcllroy JH, Jones BM, Rodger RSC, et al. Polymorphisms in angiotensin-converting enzyme gene and progression of IgA nephropathy. Lancet 1996;345:1540-2 https://doi.org/10.1016/S0140-6736(95)91088-3
  34. Marre M, Bernadet P, Gallois Y, Savagner F, Gutene TT, Hallab M, et al. Relationship between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal complications. Diabetes 1994:43:384-8 https://doi.org/10.2337/diabetes.43.3.384
  35. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, et al. Molecular basis of human hypertension: Role of angiotensinogen. Cell 1992;71:169-80 https://doi.org/10.1016/0092-8674(92)90275-H
  36. Ludwig E, Corneli PS, Anderson JL, Marshall HW, Lalouel JM, Ward RH. Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation 1995;91:2120-4 https://doi.org/10.1161/01.CIR.91.8.2120
  37. Schunkert H, Hense HW, Holmer SR, Stender M, Perz S, Keil U, et al. Association between a deletion polymorphism of the angiotensin converting enzyme gene and left ventricular hypertrophy. N Eng J Med 1994;330:1634-8 https://doi.org/10.1056/NEJM199406093302302
  38. Lee DY, Kim W, Kang SK, Koh GY, Park SK. Angiotensin-converting enzyme gene polymorphism in patients with minimal change nephrotic syndrom and focal segmental glomerulosclerosis. Nephron 1997;77:471-3 https://doi.org/10.1159/000190326
  39. Oh TG, Shin CS, Park KS, Kim SY, Cho BY, Lee HK, et al. Relationships between angiotensin I converting enzyme gene polymorphism and Renal complication in Korea IDDM patients. Korean J Intern Med 1996;11:13-6
  40. Fujisawa T, Ueda H, Ikegami H, Rakugi H, Shen GQ, Higaki J. et al. Angiotensin I converting enzyme gene polymorphism is associated with myocardial infarction, but not with retinopathy or nephropathy in NIDDM. Diabetes Care 1995;18:983-5 https://doi.org/10.2337/diacare.18.7.983